Evidence map›Paper›PMID 38060502›Full record

ArticleAnalytical chemistry2023

Nanomolar Protein Thermal Profiling with Modified Cyanine Dyes.

Morteza Malakoutikhah, Randa Mahran, Negin Gooran, Ahmadreza Masoumi, Katri Lundell, Arto Liljeblad, Keelan Guiley, Shizhong Dai, Qinheng Zheng, Lawrence Zhu and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Fluorescence-Based Protein Stability Monitoring-A Review.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Morteza MalakoutikhahDepartment of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.ORCID 0000-0003-1856-996X
Randa MahranDepartment of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.
Negin GooranDepartment of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.
Ahmadreza MasoumiDepartment of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.
Katri LundellLaboratory of Synthetic Drug Chemistry, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, FI-20520 Turku, Finland.
Arto LiljebladLaboratory of Synthetic Drug Chemistry, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, FI-20520 Turku, Finland.
Keelan GuileyDepartment of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California, San Francisco, California 94158, United States.
Shizhong DaiDepartment of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California, San Francisco, California 94158, United States.ORCID 0000-0001-9679-2353
Qinheng ZhengDepartment of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California, San Francisco, California 94158, United States.ORCID 0000-0002-8440-8673
Lawrence ZhuDepartment of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California, San Francisco, California 94158, United States.
Kevan M ShokatDepartment of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California, San Francisco, California 94158, United States.ORCID 0000-0001-8590-7741
Kari KopraDepartment of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.ORCID 0000-0001-7585-6020
Harri HärmäDepartment of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.ORCID 0000-0002-8936-039X
University of Turku · FIHoward Hughes Medical Institute · US

Funding

Research Training in Chemistry and Chemical BiologyT32GM145460 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jason E Gestwicki · 2022 to 2026
$3.1M
NIGMS NIH HHS T32 GM145460
6 · The paper itself

Abstract

Protein properties and interactions have been widely investigated by using external labels. However, the micromolar sensitivity of the current dyes limits their applicability due to the high material consumption and assay cost. In response to this challenge, we synthesized a series of cyanine5 (Cy5) dye-based quencher molecules to develop an external dye technique to probe proteins at the nanomolar protein level in a high-throughput one-step assay format. Several families of Cy5 dye-based quenchers with ring and/or side-chain modifications were designed and synthesized by introducing organic small molecules or peptides. Our results showed that steric hindrance and electrostatic interactions are more important than hydrophobicity in the interaction between the luminescent negatively charged europium-chelate-labeled peptide (Eu-probe) and the quencher molecules. The presence of substituents on the quencher indolenine rings reduces their quenching property, whereas the increased positive charge on the indolenine side chain improved the interaction between the quenchers and the luminescent compound. The designed quencher structures entirely altered the dynamics of the Eu-probe (protein-probe) for studying protein stability and interactions, as we were able to reduce the quencher concentration 100-fold. Moreover, the new quencher molecules allowed us to conduct the experiments using neutral buffer conditions, known as the peptide-probe assay. These improvements enabled us to apply the method in a one-step format for nanomolar protein-ligand interaction and protein profiling studies instead of the previously developed two-step protocol. These improvements provide a faster and simpler method with lower material consumption.

Indexed as

Coloring AgentsPeptidesCarbocyaninesFluorescent DyesLuminescenceCarbocyaninesColoring Agentscyanine dye 5Fluorescent DyesPeptides

Identifiers

PMID38060502
PMCPMC10733900
OpenAlexW4389429548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.